Scandinavian Real Heart AB (Publ) (HEART.ST)
SEK 12.54
(-2.79%)
SEK 12.54
(-2.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 102.63 Million SEK | -14.34% |
| 2022 | 119.81 Million SEK | 1.7% |
| 2021 | 117.81 Million SEK | 50.96% |
| 2020 | 78.04 Million SEK | 17.16% |
| 2019 | 66.61 Million SEK | 142.9% |
| 2018 | 27.42 Million SEK | -19.24% |
| 2017 | 33.95 Million SEK | 68.05% |
| 2016 | 20.2 Million SEK | 206.24% |
| 2015 | 6.59 Million SEK | -21.02% |
| 2014 | 8.35 Million SEK | 504.02% |
| 2013 | 1.38 Million SEK | 11.79% |
| 2012 | 1.23 Million SEK | 41.65% |
| 2011 | 873.52 Thousand SEK | -10.06% |
| 2010 | 971.28 Thousand SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 93.73 Million SEK | -8.68% |
| 2024 Q2 | 86.64 Million SEK | -7.57% |
| 2023 Q3 | 150.14 Million SEK | 27.67% |
| 2023 FY | 102.63 Million SEK | -14.34% |
| 2023 Q4 | 102.63 Million SEK | -31.64% |
| 2023 Q1 | 119.48 Million SEK | -0.28% |
| 2023 Q2 | 117.59 Million SEK | -1.58% |
| 2022 Q1 | 114.47 Million SEK | -2.83% |
| 2022 Q2 | 112.89 Million SEK | -1.39% |
| 2022 Q4 | 119.81 Million SEK | -1.79% |
| 2022 Q3 | 122 Million SEK | 8.07% |
| 2022 FY | 119.81 Million SEK | 1.7% |
| 2021 Q2 | 81.41 Million SEK | 6.73% |
| 2021 Q1 | 76.27 Million SEK | -2.26% |
| 2021 Q3 | 140.66 Million SEK | 72.79% |
| 2021 Q4 | 117.81 Million SEK | -16.25% |
| 2021 FY | 117.81 Million SEK | 50.96% |
| 2020 Q3 | 80.31 Million SEK | 25.76% |
| 2020 FY | 78.04 Million SEK | 17.16% |
| 2020 Q1 | 64.33 Million SEK | -3.42% |
| 2020 Q4 | 78.04 Million SEK | -2.83% |
| 2020 Q2 | 63.86 Million SEK | -0.73% |
| 2019 FY | 66.61 Million SEK | 142.9% |
| 2019 Q1 | 72.12 Million SEK | 162.99% |
| 2019 Q2 | 69.12 Million SEK | -4.16% |
| 2019 Q3 | 68.17 Million SEK | -1.38% |
| 2019 Q4 | 66.61 Million SEK | -2.29% |
| 2018 Q1 | 31.16 Million SEK | -8.22% |
| 2018 FY | 27.42 Million SEK | -19.24% |
| 2018 Q4 | 27.42 Million SEK | -6.33% |
| 2018 Q3 | 29.27 Million SEK | -4.16% |
| 2018 Q2 | 30.54 Million SEK | -1.99% |
| 2017 FY | 33.95 Million SEK | 68.05% |
| 2017 Q3 | 18.52 Million SEK | 2.81% |
| 2017 Q4 | 33.95 Million SEK | 83.3% |
| 2017 Q2 | 18.02 Million SEK | -8.73% |
| 2017 Q1 | 19.74 Million SEK | -1.12% |
| 2016 Q2 | 18.82 Million SEK | 0.0% |
| 2016 Q4 | 19.96 Million SEK | -6.71% |
| 2016 FY | 20.2 Million SEK | 206.24% |
| 2016 Q3 | 21.4 Million SEK | 13.7% |
| 2015 Q2 | 7.26 Million SEK | -1.98% |
| 2015 FY | 6.59 Million SEK | -21.02% |
| 2015 Q4 | 6.59 Million SEK | -12.87% |
| 2015 Q3 | 7.57 Million SEK | 4.22% |
| 2015 Q1 | 7.41 Million SEK | -11.27% |
| 2014 Q4 | 8.35 Million SEK | 0.0% |
| 2014 FY | 8.35 Million SEK | 504.02% |
| 2013 FY | 1.38 Million SEK | 11.79% |
| 2012 FY | 1.23 Million SEK | 41.65% |
| 2011 FY | 873.52 Thousand SEK | -10.06% |
| 2010 FY | 971.28 Thousand SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -63.218% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.878% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.878% |
| Arcoma AB | 81.96 Million SEK | -25.227% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 84.97% |
| BICO Group AB (publ) | 10.19 Billion SEK | 98.993% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 86.407% |
| CellaVision AB (publ) | 928.71 Million SEK | 88.948% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -77.806% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -367.484% |
| C-Rad AB (publ) | 404 Million SEK | 74.594% |
| Duearity AB (publ) | 15.14 Million SEK | -577.749% |
| Dignitana AB (publ) | 44.83 Million SEK | -128.945% |
| Episurf Medical AB (publ) | 104.3 Million SEK | 1.593% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.814% |
| Iconovo AB (publ) | 128.07 Million SEK | 19.864% |
| Integrum AB (publ) | 164.85 Million SEK | 37.742% |
| Luxbright AB (publ) | 40.68 Million SEK | -152.265% |
| Mentice AB (publ) | 322.52 Million SEK | 68.177% |
| OssDsign AB (publ) | 356.38 Million SEK | 71.2% |
| Paxman AB (publ) | 167.12 Million SEK | 38.586% |
| Promimic AB (publ) | 92.87 Million SEK | -10.512% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -162.865% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -59.54% |
| ScandiDos AB (publ) | 81.47 Million SEK | -25.978% |
| Sectra AB (publ) | 3.21 Billion SEK | 96.803% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 89.878% |
| Senzime AB (publ) | 433.54 Million SEK | 76.326% |
| SpectraCure AB (publ) | 144.83 Million SEK | 29.134% |
| Stille AB | 804.89 Million SEK | 87.248% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.374% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 95.325% |